Tacrolimus and Blood glucose fluctuation - a phase IV clinical study of FDA data

Summary:

Blood glucose fluctuation is reported as a side effect among people who take Tacrolimus (tacrolimus), especially for people who are male, 60+ old, have been taking the drug for 6 - 12 months also take Amlodipine, and have Diabetes.

The phase IV clinical study analyzes which people have Blood glucose fluctuation when taking Tacrolimus. It is created by eHealthMe based on reports of 115,828 people who have side effects when taking Tacrolimus from the FDA, and is updated regularly.

What is Tacrolimus?

Tacrolimus has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 116,160 Tacrolimus users. Check the latest studies of Tacrolimus.

What is Blood glucose fluctuation?

Blood glucose fluctuation is found to be associated with 640 drugs and 825 conditions by eHealthMe. Check the latest studies of Blood glucose fluctuation.

On Jun, 12, 2026

115,828 people reported to have side effects when taking Tacrolimus.
Among them, 28 people (0.02%) have Blood glucose fluctuation.

Could Tacrolimus cause Blood glucose fluctuation?

Among these 28 people:

How long have people been on Tacrolimus when they have Blood glucose fluctuation? *

What is the gender of people who have Blood glucose fluctuation when taking Tacrolimus? *

female: 14.29 %
male: 85.71 %

What is the age of people who have Blood glucose fluctuation when taking Tacrolimus? *

What are other drugs people take besides Tacrolimus? *

Amlodipine: 6 people, 21.43%
Pantoprazole: 5 people, 17.86%
Bactrim: 3 people, 10.71%
Cellcept: 3 people, 10.71%
Methylprednisolone: 3 people, 10.71%
Potassium: 3 people, 10.71%
Humalog: 3 people, 10.71%
Sodium Bicarbonate In Plastic Container: 3 people, 10.71%
Insulin: 3 people, 10.71%
Lantus: 3 people, 10.71%

What are other side effects people have besides Blood glucose fluctuation? *

Weight Decreased: 6 people, 21.43%
Acute Kidney Failure: 5 people, 17.86%
Diarrhea: 4 people, 14.29%
Weakness: 4 people, 14.29%
Liver Transplant Rejection (failure of liver transplant): 4 people, 14.29%
Inflammation: 3 people, 10.71%
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 3 people, 10.71%
Hypoglycemia (low blood sugar): 3 people, 10.71%
Hyperkalemia (damage to or disease of the kidney): 3 people, 10.71%
Hyperglycemia (high blood sugar): 3 people, 10.71%

What are the existing conditions these people have? *

Diabetes: 5 people, 17.86%
Type 2 Diabetes: 4 people, 14.29%
Blood Pressure Abnormal: 3 people, 10.71%
Cardiac Disorder: 3 people, 10.71%
Hyperglycemia (high blood sugar): 2 people, 7.14%
High Blood Pressure: 2 people, 7.14%
Fungal Infection: 1 person, 3.57%
Bacterial Infection: 1 person, 3.57%
Colon Cancer Metastatic (cancer of colon spreads to other part of body): 1 person, 3.57%
Colon Cancer Stage Iv: 1 person, 3.57%

* Approximation only. Some reports may have incomplete information.

Do you take Tacrolimus and have Blood glucose fluctuation?

- Check whether Blood glucose fluctuation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tacrolimus:

Tacrolimus (116,160 reports)

Browse all side effects of Tacrolimus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Blood glucose fluctuation:

Blood glucose fluctuation (640 drugs)

Browse all the conditions that are associated with Blood glucose fluctuation:

Blood glucose fluctuation (825 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tacrolimus (the active ingredients of Tacrolimus) and Tacrolimus (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.